Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MVD | P53602 | 1/20 | 0.47 |
| ▸ | GGPS1 | O95749 | 8/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 2/20 | 0.32 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.30 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14365954 | 0.89 | MVD (0.47) | MVDGGPS1LPAR3LPAR1S1PR2 | |
| SCHEMBL15586931 | 0.85 | MVD (0.47) | MVDGGPS1LPAR3LPAR1LPAR2 | |
| SCHEMBL2628074 | 0.84 | MVD (0.42) | MVDGGPS1LPAR3LPAR1LPAR2 | |
| SCHEMBL3489299 | 0.82 | MVD (0.47) | MVDGGPS1LPAR3LPAR1LPAR2 | |
| SCHEMBL497177 | 0.81 | LPAR3 (0.46) | LPAR3LPAR1LPAR2MEN1KMT2A | |
| SCHEMBL13618507 | 0.80 | MVD (0.41) | MVDGGPS1LPAR3LPAR1LPAR2 | |
| SCHEMBL18161272 | 0.80 | MVD (0.41) | MVDGGPS1 | |
| SCHEMBL7263489 | 0.79 | LPAR3 (0.44) | LPAR3LPAR1LPAR2MEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL128358 | 0.79 | LPAR3 (0.44) | LPAR3LPAR1LPAR2MEN1KMT2A | |
| SCHEMBL7005822 | 0.79 | LPAR3 (0.44) | LPAR3LPAR1LPAR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9295747-B2 | Contact lens care preparation and packaging solution | NOF CORPORATION (JP) | 2016-03-29 | — | — | US | disclosed |
| US-20150306118-A9 | EXTERNAL SKIN AGENT COMPRISING MODIFIED CLAY FOR PREVENTING INFLAMMATION | POLA CHEMICAL INDUSTRIES INC. (JP) | 2015-10-29 | — | — | US | disclosed |
| US-20150051170-A2 | EXTERNAL SKIN AGENT COMPRISING MODIFIED CLAY FOR PREVENTING INFLAMMATION | POLA CHEMICAL INDUSTRIES INC. (JP) | 2015-02-19 | — | — | US | disclosed |
| US-20150024987-A1 | CONTACT LENS CARE PREPARATION AND PACKAGING SOLUTION | NOF CORPORATION (JP) | 2015-01-22 | — | — | US | disclosed |
| US-20140235577-A1 | EXTERNAL SKIN AGENT COMPRISING MODIFIED CLAY FOR PREVENTING INFLAMMATION | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-8741323-B2 | External skin agent comprising modified clay for preventing inflammation | POLA CHEMICAL INDUSTRIES INC. (JP) | 2014-06-03 | — | — | US | disclosed |
| US-20100003210-A1 | EXTERNAL SKIN AGENT COMPRISING MODIFIED CLAY FOR PREVENTING INFLAMMATION | POLA CHEMICAL INDUSTRIES INC. (JP) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100003210-A1 | EXTERNAL SKIN AGENT COMPRISING MODIFIED CLAY FOR PREVENTING INFLAMMATION | CUTA, TSLP, NFKBIA | MVD 4677/4885GGPS1 4783/4885LPAR3 1842/4885 |
| US-20140235577-A1 | EXTERNAL SKIN AGENT COMPRISING MODIFIED CLAY FOR PREVENTING INFLAMMATION | CUTA, TSLP, NFKBIA | MVD 4677/4885GGPS1 4783/4885LPAR3 1842/4885 |
| US-20150051170-A2 | EXTERNAL SKIN AGENT COMPRISING MODIFIED CLAY FOR PREVENTING INFLAMMATION | CUTA, TSLP, NFKBIA | MVD 4677/4885GGPS1 4783/4885LPAR3 1842/4885 |
| US-20150306118-A9 | EXTERNAL SKIN AGENT COMPRISING MODIFIED CLAY FOR PREVENTING INFLAMMATION | CUTA, TSLP, NFKBIA | MVD 4677/4885GGPS1 4783/4885LPAR3 1842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.